Substance Use Disorders (SUD) have touched many communities across the United States, claiming the lives of many. While promising progress has been made in reducing the impact of SUD on society, novel and expanded efforts are still required to continue advancing this progress. Pharmacists utilizing Comprehensive Medication Management (CMM) within an alcohol and drug treatment center have been a part of this effort to expand innovative practices to combat the SUD crisis. The objectives of this report are to (1) characterize the residential patient population served at the Center for Alcohol and Drug Treatment (CADT), (2) describe the medication therapy problems (MTPs) identified and resolved over the first 12 months of implementation of CMM in the residential inpatient SUD treatment setting, and (3) discuss the expansion of CMM implementation in a residential inpatient SUD treatment setting.
Methods
A prospective, observational, descriptive report analyzing the impact of CMM services provided.
Results
Over the 12-month implementation period, CMM services were provided to 165 patients at 295 visits. On average, 7.3 medications (range 0–26), 3.9 (1–14) conditions, and 2 (0–6) MTPs were evaluated per encounter. Major findings included 72.4% of MTPs being resolved during or after the visit and a lack of adequate payment for CMM services to be financially viable.
Conclusion
The expansion of CMM services at the CADT led to a high resolution rate (72.4%) of MTPs in the first year and is an example of an innovative and novel way that pharmacy practice can combat the SUD crisis. However, payment for CMM services is a barrier to implementation and sustainability.
{"title":"Pharmacist-Delivered Comprehensive Medication Management in a Substance Use Disorder Inpatient Residential Treatment Program, a 12-Month Descriptive Report","authors":"Lucas Kosobuski, Laura Palombi, Keri Hager","doi":"10.1002/jac5.70159","DOIUrl":"https://doi.org/10.1002/jac5.70159","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Substance Use Disorders (SUD) have touched many communities across the United States, claiming the lives of many. While promising progress has been made in reducing the impact of SUD on society, novel and expanded efforts are still required to continue advancing this progress. Pharmacists utilizing Comprehensive Medication Management (CMM) within an alcohol and drug treatment center have been a part of this effort to expand innovative practices to combat the SUD crisis. The objectives of this report are to (1) characterize the residential patient population served at the Center for Alcohol and Drug Treatment (CADT), (2) describe the medication therapy problems (MTPs) identified and resolved over the first 12 months of implementation of CMM in the residential inpatient SUD treatment setting, and (3) discuss the expansion of CMM implementation in a residential inpatient SUD treatment setting.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A prospective, observational, descriptive report analyzing the impact of CMM services provided.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Over the 12-month implementation period, CMM services were provided to 165 patients at 295 visits. On average, 7.3 medications (range 0–26), 3.9 (1–14) conditions, and 2 (0–6) MTPs were evaluated per encounter. Major findings included 72.4% of MTPs being resolved during or after the visit and a lack of adequate payment for CMM services to be financially viable.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The expansion of CMM services at the CADT led to a high resolution rate (72.4%) of MTPs in the first year and is an example of an innovative and novel way that pharmacy practice can combat the SUD crisis. However, payment for CMM services is a barrier to implementation and sustainability.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70159","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145915831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Selena Xu, Arden R. Barry, Soroush Basiratmanesh, Peter S. Loewen, Robert T. Pammett, Parkash Ragsdale, Theresa L. Charrois, Yiu-Ching Jennifer Wong, Karen Dahri
Background
Scope of practice for pharmacists in Canada has expanded to include prescribing for minor ailments and conditions (MAC). In June 2023, the province of British Columbia (BC), Canada introduced pharmacist prescribing for 21 common MAC, as well as contraception. The objective of this study is to ascertain patients' perspectives regarding pharmacist prescribing and evaluate their experiences with accessing the pharmacist prescribing for MAC/contraception service.
Methods
This was a prospective, cross-sectional study that utilized an anonymous, online survey. The intended population was residents of bc 18 years of age and older. The survey included 34 questions in three sections: demographics, general perceptions of pharmacist prescribing, and experience with accessing the pharmacist prescribing for MAC/contraception service. Pharmacists or student pharmacists, or those who resided with one, were excluded.
Results
Two hundred and seven respondents submitted the survey. Fifty-eight percent of patients were less than 50 years of age and 77% were women. Results indicated that respondents recognized pharmacists' medication expertise and trusted their ability to maintain confidentiality. Respondents were in favor of pharmacists' authority to change a prescription (e.g., due to an interaction), while most disagreed that only doctors should write or modify prescriptions. Respondents agreed that pharmacists should have additional authority, such as the ability to order laboratory tests or refer patients to specialists. A majority of respondents (181/204, 89%) were aware that pharmacists can safely and effectively prescribe for MAC/contraception. Thirty-seven percent (76/207) of respondents had accessed the pharmacist prescribing for MAC service. Of those, 67% (51/76) received a prescription and did not require follow-up with another health care professional after seeing the pharmacist.
Conclusions
Respondents demonstrated trust in pharmacists' knowledge of medications and competency when prescribing for a MAC or contraception. Most respondents were able to get a prescription from a pharmacist without the need to access additional health care resources.
{"title":"Patients' Perceptions of Pharmacist Prescribing for Minor Ailments and Contraception in British Columbia, Canada","authors":"Selena Xu, Arden R. Barry, Soroush Basiratmanesh, Peter S. Loewen, Robert T. Pammett, Parkash Ragsdale, Theresa L. Charrois, Yiu-Ching Jennifer Wong, Karen Dahri","doi":"10.1002/jac5.70168","DOIUrl":"https://doi.org/10.1002/jac5.70168","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Scope of practice for pharmacists in Canada has expanded to include prescribing for minor ailments and conditions (MAC). In June 2023, the province of British Columbia (BC), Canada introduced pharmacist prescribing for 21 common MAC, as well as contraception. The objective of this study is to ascertain patients' perspectives regarding pharmacist prescribing and evaluate their experiences with accessing the pharmacist prescribing for MAC/contraception service.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a prospective, cross-sectional study that utilized an anonymous, online survey. The intended population was residents of <span>bc</span> 18 years of age and older. The survey included 34 questions in three sections: demographics, general perceptions of pharmacist prescribing, and experience with accessing the pharmacist prescribing for MAC/contraception service. Pharmacists or student pharmacists, or those who resided with one, were excluded.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Two hundred and seven respondents submitted the survey. Fifty-eight percent of patients were less than 50 years of age and 77% were women. Results indicated that respondents recognized pharmacists' medication expertise and trusted their ability to maintain confidentiality. Respondents were in favor of pharmacists' authority to change a prescription (e.g., due to an interaction), while most disagreed that only doctors should write or modify prescriptions. Respondents agreed that pharmacists should have additional authority, such as the ability to order laboratory tests or refer patients to specialists. A majority of respondents (181/204, 89%) were aware that pharmacists can safely and effectively prescribe for MAC/contraception. Thirty-seven percent (76/207) of respondents had accessed the pharmacist prescribing for MAC service. Of those, 67% (51/76) received a prescription and did not require follow-up with another health care professional after seeing the pharmacist.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Respondents demonstrated trust in pharmacists' knowledge of medications and competency when prescribing for a MAC or contraception. Most respondents were able to get a prescription from a pharmacist without the need to access additional health care resources.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70168","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Limited time for counseling and infrequent follow-ups in pharmacies may affect clinical outcomes. While additional home visits by community pharmacists may improve outcomes in patients with hypertension and/or dyslipidemia, their impact in Thailand remains unstudied. The objective of this study was to compare clinical outcomes, medication adherence, and disease knowledge between patients with hypertension and/or dyslipidemia who received additional pharmaceutical care with home visits and those who received care only at a community pharmacy.
Methods
This randomized controlled study was conducted in a community pharmacy. Patients aged 20 years and older with uncontrolled hypertension and/or dyslipidemia were included. All patients received standard care in a community pharmacy dispensing service. A home visit by a pharmacist was conducted in the intervention group after 1 month and a telephone call after 3 months. Blood pressure (BP) and medication adherence were assessed at each visit, while low-density lipoprotein (LDL) cholesterol levels and disease knowledge were assessed at baseline and after 5 months. The primary outcome was the control of diseases by the end of the study.
Results
Seventy-five patients were included (38 and 37 patients in the home visit group and the control group, respectively). At the end of the study, systolic BP, diastolic BP, and LDL cholesterol levels were significantly lower in the home visit group compared with the control group (p < 0.05). Patients in the home visit group significantly achieved BP or LDL cholesterol targets compared with the control group (52.6% vs. 29.7% and 84.2% vs. 51.4%, respectively). In addition, more patients in the home visit group significantly achieved controlled hypertension from the second month (p < 0.05). Medication adherence and knowledge of hypertension and dyslipidemia were significantly higher in the home visit group compared with the control group (p < 0.05).
Conclusion
The addition of home visits by a community pharmacist improved clinical outcomes, medication adherence, and disease knowledge.
{"title":"Impact of Home Visits for Hypertension and Dyslipidemia by Community Pharmacists in Thailand: A Randomized Controlled Study","authors":"Sirin Jeanwiwattanavong, Sirima Sitaruno, Sirima Mahattanadul, Orawan Sae-lim","doi":"10.1002/jac5.70158","DOIUrl":"https://doi.org/10.1002/jac5.70158","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Limited time for counseling and infrequent follow-ups in pharmacies may affect clinical outcomes. While additional home visits by community pharmacists may improve outcomes in patients with hypertension and/or dyslipidemia, their impact in Thailand remains unstudied. The objective of this study was to compare clinical outcomes, medication adherence, and disease knowledge between patients with hypertension and/or dyslipidemia who received additional pharmaceutical care with home visits and those who received care only at a community pharmacy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This randomized controlled study was conducted in a community pharmacy. Patients aged 20 years and older with uncontrolled hypertension and/or dyslipidemia were included. All patients received standard care in a community pharmacy dispensing service. A home visit by a pharmacist was conducted in the intervention group after 1 month and a telephone call after 3 months. Blood pressure (BP) and medication adherence were assessed at each visit, while low-density lipoprotein (LDL) cholesterol levels and disease knowledge were assessed at baseline and after 5 months. The primary outcome was the control of diseases by the end of the study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Seventy-five patients were included (38 and 37 patients in the home visit group and the control group, respectively). At the end of the study, systolic BP, diastolic BP, and LDL cholesterol levels were significantly lower in the home visit group compared with the control group (<i>p</i> < 0.05). Patients in the home visit group significantly achieved BP or LDL cholesterol targets compared with the control group (52.6% vs. 29.7% and 84.2% vs. 51.4%, respectively). In addition, more patients in the home visit group significantly achieved controlled hypertension from the second month (<i>p</i> < 0.05). Medication adherence and knowledge of hypertension and dyslipidemia were significantly higher in the home visit group compared with the control group (<i>p</i> < 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The addition of home visits by a community pharmacist improved clinical outcomes, medication adherence, and disease knowledge.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145930979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"2025 ACCP Annual Meeting Abstracts","authors":"","doi":"10.1002/jac5.70148","DOIUrl":"https://doi.org/10.1002/jac5.70148","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 12","pages":"1376-1503"},"PeriodicalIF":1.5,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PSAP in JACCP: Case Series: Osteoporosis","authors":"Marissa C. Salvo, Christina M. Polomoff","doi":"10.1002/jac5.70137","DOIUrl":"https://doi.org/10.1002/jac5.70137","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 12","pages":"1370-1371"},"PeriodicalIF":1.5,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145779498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PSAP in JACCP Recorded Webcast: Deprescribing in the Older Adult","authors":"Ryan C. Costantino","doi":"10.1002/jac5.70136","DOIUrl":"https://doi.org/10.1002/jac5.70136","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 12","pages":"1368-1369"},"PeriodicalIF":1.5,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mojdeh S. Heavner, Kelli Henry, Andrea Sikora, Susan E. Smith, OPTIM Investigator Team
It is challenging to generate data sufficient to assess the complex relationships between pharmacist workload and patient outcomes. The purpose of this paper is to describe innovative methods of recruitment and retention in engaging health professionals as study participants in a multicenter effort to collect workload data for a large investigation of pharmacist-to-patient ratios and patient-centered outcomes in the intensive care unit (ICU). In the Optimizing Pharmacist-Team Integration for ICU patient Management (OPTIM) study, critical care pharmacists (CCPs) were recruited to prospectively collect data on workload for 100 days before a retrospective data analysis period. This design was essential for robust, externally generalizable analysis of workload relationships to patient-centered outcomes. Recruitment and retention strategies to support this study design are illustrated. Recruitment strategies used professional association listservs, engagement of pharmacy residency programs, and information sessions. Retention strategies included newsletters, office hours, enrichment sessions, OPTIM-related marketing, in-person networking, and authorship potential. This resulted in study completion by 64 sites with 31 832 adult patients, 207 CCPs, 53 trainees, and 22 additional investigators supporting data collection with a missingness rate of less than 2%. Recruitment and retention strategies to promote teamwork without large-scale funding were successful in generating the largest database of CCP workloads and patient-level data.
{"title":"Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM): Recruitment and Retention Strategies to Mobilize a Professional Community","authors":"Mojdeh S. Heavner, Kelli Henry, Andrea Sikora, Susan E. Smith, OPTIM Investigator Team","doi":"10.1002/jac5.70154","DOIUrl":"https://doi.org/10.1002/jac5.70154","url":null,"abstract":"<p>It is challenging to generate data sufficient to assess the complex relationships between pharmacist workload and patient outcomes. The purpose of this paper is to describe innovative methods of recruitment and retention in engaging health professionals as study participants in a multicenter effort to collect workload data for a large investigation of pharmacist-to-patient ratios and patient-centered outcomes in the intensive care unit (ICU). In the Optimizing Pharmacist-Team Integration for ICU patient Management (OPTIM) study, critical care pharmacists (CCPs) were recruited to prospectively collect data on workload for 100 days before a retrospective data analysis period. This design was essential for robust, externally generalizable analysis of workload relationships to patient-centered outcomes. Recruitment and retention strategies to support this study design are illustrated. Recruitment strategies used professional association listservs, engagement of pharmacy residency programs, and information sessions. Retention strategies included newsletters, office hours, enrichment sessions, OPTIM-related marketing, in-person networking, and authorship potential. This resulted in study completion by 64 sites with 31 832 adult patients, 207 CCPs, 53 trainees, and 22 additional investigators supporting data collection with a missingness rate of less than 2%. Recruitment and retention strategies to promote teamwork without large-scale funding were successful in generating the largest database of CCP workloads and patient-level data.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70154","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145969679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annika K. Coley, Megan A. Anweiler, Brooke M. Wallace, Jamie N. Brown
Background
Formal training in medical writing provides numerous benefits for pharmacy residents including the development of writing and scholarship fundamentals, enhancement of time and project management skills, and cultivation of mentoring relationships. Literature describing the outcomes of a dedicated medical writing rotation is limited. The objective of this study was to describe publication and citation outcomes associated with the implementation of a medical writing rotation for post-graduate year two (PGY2) pharmacy residents at a Veterans Affairs health care system.
Methods
All publication activities for residents that participated in the medical writing rotation between July 1, 2011 and June 30, 2024 were included for review. A literature search was conducted using the PubMed, Embase, and Scopus databases for each included resident, and both Scopus and individual journal websites were utilized to collect journal and publication level metrics.
Results
Forty PGY2 pharmacy residents (3.1 residents per year) participated in the medical writing rotation. Of those, 35 (87.5%) residents were successful in publishing at least one manuscript developed during the rotation, resulting in 32 total publications. The majority of publications were review articles (84.4%). The total number of times one of the publications was cited by another published article was 596, representing a median of 16.5 (range: 2–61) citations per publication. The calculated h-index for all publications from the rotation was 16. A median of 1 (range: 1–3) pharmacy preceptors were involved as a co-author for each publication with a total of 15 different preceptors co-authoring at least one publication. After the completion of the rotation, 28 of 38 (73.7%) residents authored at least one future publication.
Conclusion
Implementation of a medical writing rotation helps residents develop foundational scholarship skills to make meaningful contributions to the medical literature while supporting preceptor development and resident collaboration.
{"title":"Scholarship Outcomes and Opportunities of a Medical Writing Rotation for Pharmacy Residents","authors":"Annika K. Coley, Megan A. Anweiler, Brooke M. Wallace, Jamie N. Brown","doi":"10.1002/jac5.70157","DOIUrl":"https://doi.org/10.1002/jac5.70157","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Formal training in medical writing provides numerous benefits for pharmacy residents including the development of writing and scholarship fundamentals, enhancement of time and project management skills, and cultivation of mentoring relationships. Literature describing the outcomes of a dedicated medical writing rotation is limited. The objective of this study was to describe publication and citation outcomes associated with the implementation of a medical writing rotation for post-graduate year two (PGY2) pharmacy residents at a Veterans Affairs health care system.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>All publication activities for residents that participated in the medical writing rotation between July 1, 2011 and June 30, 2024 were included for review. A literature search was conducted using the PubMed, Embase, and Scopus databases for each included resident, and both Scopus and individual journal websites were utilized to collect journal and publication level metrics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Forty PGY2 pharmacy residents (3.1 residents per year) participated in the medical writing rotation. Of those, 35 (87.5%) residents were successful in publishing at least one manuscript developed during the rotation, resulting in 32 total publications. The majority of publications were review articles (84.4%). The total number of times one of the publications was cited by another published article was 596, representing a median of 16.5 (range: 2–61) citations per publication. The calculated h-index for all publications from the rotation was 16. A median of 1 (range: 1–3) pharmacy preceptors were involved as a co-author for each publication with a total of 15 different preceptors co-authoring at least one publication. After the completion of the rotation, 28 of 38 (73.7%) residents authored at least one future publication.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Implementation of a medical writing rotation helps residents develop foundational scholarship skills to make meaningful contributions to the medical literature while supporting preceptor development and resident collaboration.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145969747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Caitlin Brown, Kellyn Engstrom, Brian Gilbert, Brett Faine, Alicia Mattson, Kristin Cole, Fernanda Bellolio, Nicole M. Acquisto, Erin Wieruszewski, Kevin Mercer, Dana Gerberi, Alejandro Rabinstein, Megan A. Rech
Background
Intracranial and extracranial hemorrhages are significant causes of morbidity and mortality. Emergency medicine pharmacists (EMPs) can play a crucial role in anticoagulation reversal by identifying patients on anticoagulation, selecting the optimal anticoagulation reversal agent, and ensuring adequate dosing and prompt administration. The goal of this systematic review and meta-analysis was to determine the impact EMPs have on time to anticoagulation reversal and patient outcomes in anticoagulation-associated hemorrhages.
Methods
A medical librarian performed a literature search in EBSCO CINAHL, Ovid Cochrane Central Register of Controlled Trials, Ovid Embase, Ovid Medline, Scopus, and Web of Science Core Collection from inception to January 2025 for all types of oral anticoagulants and for life-threatening bleeding that required emergent reversal. Newcastle-Ottawa was used to assess the risk of bias, and Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to assess the level of certainty of the evidence. Random effects models estimating mean differences and 95% confidence intervals are reported.
Results
There were 2445 titles and abstracts screened, with 44 undergoing full-text evaluation. Six observational studies including 219 patients who received an anticoagulation reversal agent with the presence of an EMP and 198 patients who received a reversal agent without an EMP were included. Time from emergency department (ED) presentation to anticoagulation reversal agent administration (75.60 min, 95% confidence interval [CI]: −101.7 to −49.5) and time from medication order to administration were faster with an EMP (−18.7 min, 95% CI: −23.5 to −14.0). There was no difference in short-term mortality. The included studies had a high risk of bias and were deemed very low quality of evidence.
Conclusion
EMP involvement in patient care during anticoagulation reversal of acute hemorrhages improved time to anticoagulation reversal agent administration. Larger scale, higher-quality studies are necessary to assess the value of EMPs in improving patient-centered outcomes.
{"title":"Evaluation of Emergency Medicine Pharmacist Participation in Time to Oral Anticoagulation Reversal: A Systematic Review and Meta-Analysis","authors":"Caitlin Brown, Kellyn Engstrom, Brian Gilbert, Brett Faine, Alicia Mattson, Kristin Cole, Fernanda Bellolio, Nicole M. Acquisto, Erin Wieruszewski, Kevin Mercer, Dana Gerberi, Alejandro Rabinstein, Megan A. Rech","doi":"10.1002/jac5.70156","DOIUrl":"https://doi.org/10.1002/jac5.70156","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Intracranial and extracranial hemorrhages are significant causes of morbidity and mortality. Emergency medicine pharmacists (EMPs) can play a crucial role in anticoagulation reversal by identifying patients on anticoagulation, selecting the optimal anticoagulation reversal agent, and ensuring adequate dosing and prompt administration. The goal of this systematic review and meta-analysis was to determine the impact EMPs have on time to anticoagulation reversal and patient outcomes in anticoagulation-associated hemorrhages.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A medical librarian performed a literature search in EBSCO CINAHL, Ovid Cochrane Central Register of Controlled Trials, Ovid Embase, Ovid Medline, Scopus, and Web of Science Core Collection from inception to January 2025 for all types of oral anticoagulants and for life-threatening bleeding that required emergent reversal. Newcastle-Ottawa was used to assess the risk of bias, and Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to assess the level of certainty of the evidence. Random effects models estimating mean differences and 95% confidence intervals are reported.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 2445 titles and abstracts screened, with 44 undergoing full-text evaluation. Six observational studies including 219 patients who received an anticoagulation reversal agent with the presence of an EMP and 198 patients who received a reversal agent without an EMP were included. Time from emergency department (ED) presentation to anticoagulation reversal agent administration (75.60 min, 95% confidence interval [CI]: −101.7 to −49.5) and time from medication order to administration were faster with an EMP (−18.7 min, 95% CI: −23.5 to −14.0). There was no difference in short-term mortality. The included studies had a high risk of bias and were deemed very low quality of evidence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>EMP involvement in patient care during anticoagulation reversal of acute hemorrhages improved time to anticoagulation reversal agent administration. Larger scale, higher-quality studies are necessary to assess the value of EMPs in improving patient-centered outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145987071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The opioid crisis remains a significant public health concern in the United States, with escalating rates of overdose and poisoning. However, health care professional schools have limited curricular time to address this issue. In response, faculty at Roseman University and Touro University have developed an Interprofessional Education (IPE) annual event to improve student understanding and comfort levels in addressing substance use disorder (SUD) and reduce stigma toward SUD among health care professional students. The objective of this study is to evaluate the effect of a SUD-focused IPE education among health care professional students on stigma levels and comfort levels in addressing SUD with persons with SUD.
Methods
An anonymous cross-sectional study was conducted using pre- and post-IPE surveys in Qualtrics. In 2023 and 2025, IPE students from four health care programs (Pharm.D., BSN, PA, and DO) were invited to complete surveys rating their comfort level with speaking about naloxone and familiarity with community resources. Students also answered the Medical Condition Regard Scale (MCRS) survey to determine their level of stigma related to SUD. Pre- and post-IPE results were compared from year to year and by program.
Results
Over 430 health care professional students participated in the SUD-focused IPE events. All survey response rates were over 50%. Over 60% of respondents were female, and PA and Pharm.D. were the most represented programs. In both years, all programs reported increased comfort in counseling and initiating conversations about naloxone and familiarity with community resources for SUD. There was an increase in MCRS scores for all programs, indicating reduced stigma (p < 0.001).
Conclusion
IPE continues to be a great opportunity to impact future health professionals' comfort levels in initiating critical conversations surrounding substance use, providing overdose prevention counseling, and increasing awareness of community resources, all while significantly reducing stigma.
{"title":"Impact of Interprofessional Education on Health Professional Student Knowledge and Stigmatizing Beliefs Related to Substance Use Disorders: A Pre–Post Analysis","authors":"Krystal Riccio, Alana Whittaker","doi":"10.1002/jac5.70151","DOIUrl":"https://doi.org/10.1002/jac5.70151","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The opioid crisis remains a significant public health concern in the United States, with escalating rates of overdose and poisoning. However, health care professional schools have limited curricular time to address this issue. In response, faculty at Roseman University and Touro University have developed an Interprofessional Education (IPE) annual event to improve student understanding and comfort levels in addressing substance use disorder (SUD) and reduce stigma toward SUD among health care professional students. The objective of this study is to evaluate the effect of a SUD-focused IPE education among health care professional students on stigma levels and comfort levels in addressing SUD with persons with SUD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An anonymous cross-sectional study was conducted using pre- and post-IPE surveys in Qualtrics. In 2023 and 2025, IPE students from four health care programs (Pharm.D., BSN, PA, and DO) were invited to complete surveys rating their comfort level with speaking about naloxone and familiarity with community resources. Students also answered the Medical Condition Regard Scale (MCRS) survey to determine their level of stigma related to SUD. Pre- and post-IPE results were compared from year to year and by program.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Over 430 health care professional students participated in the SUD-focused IPE events. All survey response rates were over 50%. Over 60% of respondents were female, and PA and Pharm.D. were the most represented programs. In both years, all programs reported increased comfort in counseling and initiating conversations about naloxone and familiarity with community resources for SUD. There was an increase in MCRS scores for all programs, indicating reduced stigma (<i>p</i> < 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>IPE continues to be a great opportunity to impact future health professionals' comfort levels in initiating critical conversations surrounding substance use, providing overdose prevention counseling, and increasing awareness of community resources, all while significantly reducing stigma.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"9 2","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号